Cigna Investments’s National Instruments Corp NATI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,629
Closed -$200K 788
2021
Q1
$200K Buy
4,629
+73
+2% +$3.21K 0.01% 746
2020
Q4
$200K Buy
+4,556
New +$170K 0.02% 701
2020
Q3
Sell
-35,327
Closed -$1.37M 774
2020
Q2
$1.37M Buy
35,327
+817
+2% +$30.9K 0.13% 154
2020
Q1
$1.14M Buy
34,510
+200
+0.6% +$7.99K 0.15% 157
2019
Q4
$1.53M Buy
34,310
+899
+3% +$37.6K 0.16% 149
2019
Q3
$1.38M Buy
33,411
+3,769
+13% +$162K 0.14% 177
2019
Q2
$1.24M Sell
29,642
-200
-0.7% -$8.53K 0.13% 199
2019
Q1
$1.32M Buy
29,842
+13,398
+81% +$607K 0.15% 165
2018
Q4
$747K Buy
+16,444
New +$768K 0.06% 227
2018
Q2
Sell
-4,032
Closed -$203K 827
2018
Q1
$203K Buy
+4,032
New +$196K 0.01% 783
2017
Q2
Sell
-6,672
Closed -$217K 863
2017
Q1
$217K Sell
6,672
-9,472
-59% -$301K 0.01% 689
2016
Q4
$498K Buy
+16,144
New +$470K 0.05% 401

Other funds holding NATI

Cigna Investments's NATI Position: Q2 2021 in Review

Cigna Investments sold out of National Instruments Corp (NATI) in Q2 2021, closing a stake of 4,629 shares — an estimated $200K sold.

Cigna Investments first reported a position in NATI in Q4 2016 and held it in 12 quarters. The position peaked at $1.53M in Q4 2019. 298 funds tracked by Wall St. Rank hold NATI as of Q2 2021.

  • Cigna Investments reported no remaining National Instruments Corp position as of Q2 2021 after selling out during the quarter.
  • Cigna Investments sold 4,629 National Instruments Corp shares in Q2 2021, an estimated $200K.
  • Cigna Investments first reported a position in National Instruments Corp in Q4 2016 and held it in 12 quarters.
  • Cigna Investments's National Instruments Corp position peaked at $1.53M in Q4 2019.
  • 298 funds tracked by Wall St. Rank held National Instruments Corp as of Q2 2021.

Based on Cigna Investments's 13F filing for Q2 2021, filed 10 Aug 2021.